COMMUNIQUÉS West-GlobeNewswire

Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 18, 2019
08/03/2019
WAYNE, Pa., March 08, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on dermatological and immuno-inflammatory diseases, today announced it will [...]
UPDATE - electroCore Appointments Multiple Industry Veterans to Key Management Positions
08/03/2019
Dr. Tony Fiorino to serve as Chief Medical Officer and Brian Posner as Chief Financial Officer BASKING RIDGE, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic [...]
Sanofi: Filing of the 2018 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report
08/03/2019
Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Filing of the 2018 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report PARIS, France - March 8, 2019 - Sanofi announces [...]
Sanofi : Dépôt du Document de Référence 2018, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
08/03/2019
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Dépôt du Document de Référence 2018, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris (France) - Le 8 mars 2019 - Sanofi [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
08/03/2019
BURLINGTON, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in four investor conferences in March. JJ Pellegrino, Chief Financial Officer, is [...]
Audited Financial Statements' Announcement for The Year Ended 31 December 2018
08/03/2019
EASTPHARMA LTD. London, 8 March 2019 - EASTPHARMA (EAST LI) announces that it is releasing its audited financial statements for the year ended 31 December 2018 and a review of its main subsidiary DEVA Holding's audited [...]
Emblem Receives Final Order Approving Arrangement With Aleafia
08/03/2019
TORONTO, March 08, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“ Emblem ” or the “ Company ”) is pleased to announce that it has received a final order from the Ontario Superior Court of Justice ( [...]
Exactus Announces Stock Split
08/03/2019
1-for-8 Effective March 11, 2019 GLEN ALLEN, Va., March 08, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products and point of care [...]
Nextech and Relatient Announce Partnership to Enhance Patient Experience and Practice Revenue
08/03/2019
Increased technology options to implement patient-centered engagement in appointment management. TAMPA, Fla., March 08, 2019 (GLOBE NEWSWIRE) -- Nextech Systems , a leading health care technology provider for specialty [...]
Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
08/03/2019
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is pleased to announce [...]
Allovate Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy Platform
08/03/2019
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Allovate Therapeutics (“Allovate ® ”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce that the European Patent [...]
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
08/03/2019
MOORESTOWN, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chief Financial [...]
Altimmune Announces $14 million Registered Direct Offering
08/03/2019
GAITHERSBURG, Md., March 08, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced it has entered into a purchase agreement with two institutional investors [...]
Alphatec Announces Participation At Canaccord and Cowen Investor Conferences in March
08/03/2019
CARLSBAD, Calif., March 08, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced it will present at two healthcare investor conferences as follows: ATEC will present [...]
Y-mAbs Therapeutics To Present At Cowen’s 39th Annual Health Care Conference
08/03/2019
NEW YORK, March 08, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy
08/03/2019
Industry Veteran John P. Sentman to Lead Strategic Sales and Partnering MIRAMAR, FL, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Olaregen Therapeutix, a subsidiary of Generex Biotechnology Corporation ( www. [...]
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.
08/03/2019
Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group; William Hilson Appointed Chief Commercial Officer TORONTO, March 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc [...]
Kaleido Biosciences to Highlight its Platform to Identify and Evaluate Microbiome Metabolic Therapies to Reduce Gut Ammonia Production in Presentation at Keystone Symposia on Microbiome
08/03/2019
LEXINGTON, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]

Pages